BRL 16.8
(-5.46%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 24.5 Billion BRL | 3.17% |
2022 | 23.75 Billion BRL | 19.87% |
2021 | 19.81 Billion BRL | 14.89% |
2020 | 17.24 Billion BRL | 44.72% |
2019 | 11.91 Billion BRL | 12.91% |
2018 | 10.55 Billion BRL | 4.21% |
2017 | 10.13 Billion BRL | -11.01% |
2016 | 11.38 Billion BRL | -28.06% |
2015 | 15.82 Billion BRL | 13.94% |
2014 | 13.88 Billion BRL | 11.08% |
2013 | 12.5 Billion BRL | -1.22% |
2012 | 12.65 Billion BRL | -5.02% |
2011 | 13.32 Billion BRL | 33.42% |
2010 | 9.98 Billion BRL | 58.84% |
2009 | 6.28 Billion BRL | 76.35% |
2008 | 3.56 Billion BRL | 80.93% |
2007 | 1.97 Billion BRL | 517.3% |
2006 | 319.22 Million BRL | 23.92% |
2005 | 257.6 Million BRL | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q2 | 25.37 Billion BRL | 0.39% |
2024 Q1 | 25.27 Billion BRL | 3.12% |
2023 Q3 | 24.27 Billion BRL | 1.93% |
2023 FY | 24.5 Billion BRL | 3.17% |
2023 Q2 | 23.81 Billion BRL | 5.74% |
2023 Q1 | 22.51 Billion BRL | -5.21% |
2023 Q4 | 24.5 Billion BRL | 0.98% |
2022 FY | 23.75 Billion BRL | 19.87% |
2022 Q1 | 20.37 Billion BRL | 2.8% |
2022 Q3 | 22.54 Billion BRL | 7.8% |
2022 Q2 | 20.91 Billion BRL | 2.67% |
2022 Q4 | 23.75 Billion BRL | 5.35% |
2021 Q2 | 18.55 Billion BRL | 3.27% |
2021 Q3 | 20.05 Billion BRL | 8.07% |
2021 Q4 | 19.81 Billion BRL | -1.17% |
2021 FY | 19.81 Billion BRL | 14.89% |
2021 Q1 | 17.96 Billion BRL | 4.16% |
2020 FY | 17.24 Billion BRL | 44.72% |
2020 Q4 | 17.24 Billion BRL | 1.05% |
2020 Q1 | 12.1 Billion BRL | 1.54% |
2020 Q2 | 15.63 Billion BRL | 29.21% |
2020 Q3 | 17.07 Billion BRL | 9.16% |
2019 Q2 | 10.52 Billion BRL | 1.92% |
2019 Q1 | 10.32 Billion BRL | -2.17% |
2019 FY | 11.91 Billion BRL | 12.91% |
2019 Q4 | 11.91 Billion BRL | 9.94% |
2019 Q3 | 10.84 Billion BRL | 3.0% |
2018 FY | 10.55 Billion BRL | 4.21% |
2018 Q4 | 10.55 Billion BRL | 3.01% |
2018 Q3 | 10.24 Billion BRL | 3.7% |
2018 Q2 | 9.88 Billion BRL | 2.09% |
2018 Q1 | 9.68 Billion BRL | -4.43% |
2017 Q4 | 10.13 Billion BRL | 2.03% |
2017 Q3 | 9.92 Billion BRL | -5.27% |
2017 Q2 | 10.48 Billion BRL | -1.48% |
2017 Q1 | 10.63 Billion BRL | -6.55% |
2017 FY | 10.13 Billion BRL | -11.01% |
2016 Q3 | 12.45 Billion BRL | -4.39% |
2016 FY | 11.48 Billion BRL | -28.06% |
2016 Q4 | 11.38 Billion BRL | -8.59% |
2016 Q2 | 13.02 Billion BRL | -2.19% |
2016 Q1 | 13.31 Billion BRL | -15.84% |
2015 Q2 | 14.26 Billion BRL | -0.11% |
2015 FY | 15.82 Billion BRL | 13.94% |
2015 Q4 | 15.82 Billion BRL | 6.4% |
2015 Q3 | 14.87 Billion BRL | 4.28% |
2015 Q1 | 14.27 Billion BRL | 2.8% |
2014 Q4 | 13.88 Billion BRL | 2.19% |
2014 Q3 | 13.59 Billion BRL | 3.64% |
2014 Q2 | 13.11 Billion BRL | 2.15% |
2014 FY | 13.88 Billion BRL | 11.08% |
2014 Q1 | 12.83 Billion BRL | 2.68% |
2013 Q1 | 12.65 Billion BRL | 0.02% |
2013 Q2 | 12.81 Billion BRL | 1.25% |
2013 Q3 | 13.29 Billion BRL | 3.76% |
2013 Q4 | 12.5 Billion BRL | -5.99% |
2013 FY | 12.5 Billion BRL | -1.22% |
2012 Q4 | 12.65 Billion BRL | -1.98% |
2012 Q1 | 13.04 Billion BRL | -2.09% |
2012 Q2 | 13.21 Billion BRL | 1.29% |
2012 Q3 | 12.91 Billion BRL | -2.3% |
2012 FY | 12.65 Billion BRL | -5.02% |
2011 Q1 | 13.03 Billion BRL | 30.5% |
2011 Q3 | 13.58 Billion BRL | -1.01% |
2011 Q2 | 13.72 Billion BRL | 5.34% |
2011 Q4 | 13.32 Billion BRL | -1.95% |
2011 FY | 13.32 Billion BRL | 33.42% |
2010 Q3 | 9.28 Billion BRL | 39.19% |
2010 FY | 9.98 Billion BRL | 58.84% |
2010 Q2 | 6.67 Billion BRL | 4.03% |
2010 Q4 | 9.98 Billion BRL | 7.55% |
2010 Q1 | 6.41 Billion BRL | 2.0% |
2009 Q4 | 6.28 Billion BRL | 0.0% |
2009 FY | 6.28 Billion BRL | 76.35% |
2008 FY | 3.56 Billion BRL | 80.93% |
2007 FY | 1.97 Billion BRL | 517.3% |
2006 FY | 319.22 Million BRL | 23.92% |
2005 FY | 257.6 Million BRL | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Blau FarmacĂȘutica S.A. | 3.05 Billion BRL | -702.637% |